Table 11.
Male |
Female |
||||||||
---|---|---|---|---|---|---|---|---|---|
Group 1, Control |
Group 2, 100 mg/kg/day |
Group 3, 300 mg/kg/day |
Group 4, 1000 mg/kg/day |
Group 1, Control |
Group 2, 100 mg/kg/day |
Group 3, 300 mg/kg/day |
Group 4, 1000 mg/kg/day |
||
Number of animals | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |
Lung | Submitted | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
N.V.L | 4 | 5 | 5 | 5 | 7 | 9 | 9 | 9 | |
Focus | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |
Focus; dark | 1 | 3 | 1 | 2 | 0 | 0 | 0 | 1 | |
Focus; pale | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | |
Discoloration; mottled | 4 | 3 | 3 | 2 | 2 | 0 | 1 | 0 | |
Lymph node, mesenteric | Submitted | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
N.V.L | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |
Muscle, skeletal | Submitted | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
N.V.L | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |
Infiltration, mononuclear cell, minimal | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |
Nerve, optic | Submitted | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
N.V.L | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |
Not examined, not present | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |
Nerve, sciatic | Submitted | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
N.V.L | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |
Ovary | Examined | – | – | – | – | 10 | 10 | 10 | 10 |
N.V.L | – | – | – | – | 10 | 10 | 10 | 10 | |
Oviduct | Submitted | – | – | – | – | 10 | 10 | 10 | 10 |
N.V.L | – | – | – | – | 10 | 10 | 10 | 10 | |
Pancreas | Submitted | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
N.V.L | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |